Pediatric Sedation Practices and Adverse Event Management

Pediatric sedation encompasses a spectrum of interventions—from minimal anxiolysis to deep sedation—tailored to the developmental stage, procedural requirements and individual risk factors of each child. Common agents include benzodiazepines (notably midazolam), alpha-2 agonists (such as dexmedetomidine), ketamine and combinations thereof, administered via oral, intranasal or intravenous routes. Sedation depth is guided by clinical scales and, in advanced settings, electroencephalographic indices. Pharmacokinetic variability in children, influenced by age, body composition and maturation of metabolic pathways, underpins the need for weight- and age-adjusted dosing. Adverse events range from common but self-limited phenomena, such as nausea or mild respiratory depression, to rare but serious outcomes including severe airway obstruction, haemodynamic instability or emergence agitation. Effective management requires pre-procedure assessment, continuous monitoring of airway patency, heart rate, blood pressure and oxygen saturation, and ready access to resuscitative equipment. Protocols for recognition and prompt treatment of respiratory compromise, hypotension or paradoxical agitation enhance safety. Emerging practice guidelines endorse standardised sedation regimens, competency-based training for practitioners and inclusion of non-pharmacological strategies to reduce drug requirements. Globally, harmonisation of paediatric sedation protocols aims to ensure safe and effective procedural care across diverse clinical settings, from tertiary hospitals to outpatient imaging centres.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Pediatric Sedation Practices and Adverse Event Management publication trend

The graph below shows the total number of articles in pediatric sedation practices and adverse event management across all publications each year (not limited to Nature Index journals).

Technical terms

Pharmacokinetics: Study of drug absorption, distribution, metabolism and excretion in the body.

Bispectral index (BIS): Quantitative electroencephalographic measure used to assess depth of sedation.

Premedication: Administration of sedative or anxiolytic drugs before a procedure to reduce anxiety and facilitate cooperation.

Emergence agitation: Acute behavioural disturbance, including confusion and restlessness, during recovery from sedation.

Deep sedation: Drug-induced depression of consciousness during which patients respond purposefully only after repeated or painful stimulation.

References

1. The MAGIC trial: a pragmatic, multicentre, parallel, noninferiority, randomised trial of melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia. British Journal of Anaesthesia (2023).
2. Influence of Age and Sex on the Pharmacokinetics of Midazolam and the Depth of Sedation in Pediatric Patients Undergoing Minor Surgeries. Pharmaceutics (2023).
3. A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial. Frontiers in Pharmacology (2022).